Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Zomedica Pharmaceuticals Q4 Sales $4.10M

Zomedica Pharmaceuticals (AMEX:ZOM) reported $4.10 million in sales this quarter.

February 25, 2022

1 minute read

Zomedica Pharmaceuticals (AMEX:ZOM) reported $4.10 million in sales this quarter.

Barclays Maintains Equal-Weight on Paychex, Raises Price Target to $140

Today, 8:44 AM

Barclays analyst Ramsey El-Assal maintains Paychex (NASDAQ:PAYX) with a Equal-Weight and raises the price target from $115 to $140.

Today, 8:44 AM

-Dow Jones

Today, 8:44 AM

B of A Securities analyst Lorraine Hutchinson initiates coverage on FIGS (NYSE:FIGS) with a Buy rating and announces Price Target of $42.

Today, 8:44 AM

https://www.washingtonpost.com/technology/2022/12/15/wyden-ftc-neustar-sussmann/